scispace - formally typeset
T

Thomas F. Lüscher

Researcher at University of Zurich

Publications -  1613
Citations -  88517

Thomas F. Lüscher is an academic researcher from University of Zurich. The author has contributed to research in topics: Endothelium & Myocardial infarction. The author has an hindex of 134, co-authored 1560 publications receiving 79034 citations. Previous affiliations of Thomas F. Lüscher include University of Texas Southwestern Medical Center & Durham University.

Papers
More filters
Journal ArticleDOI

Congenital coronary anomalies detected by coronary computed tomography compared to invasive coronary angiography

Jelena R. Ghadri, +13 more
- 08 Jul 2014 - 
TL;DR: The prevalence of coronary anomalies is substantially higher with CCTA than ICA even after exclusion of patients with myocardial bridging which is more frequently found with C CTA, suggesting that the true prevalence in the general population may have been underestimated based on ICA.
Journal ArticleDOI

Nutraceuticals in cardiovascular prevention: lessons from studies on endothelial function

Cinzia Zuchi, +3 more
- 01 Aug 2010 - 
TL;DR: The findings further support the notion that nutraceuticals do need support from large clinical outcome trials with respect to their efficacy and safety profile for cardiovascular prevention, before their widespread use can be recommended.
Journal ArticleDOI

The codex of science: honesty, precision, and truth—and its violations

Thomas F. Lüscher
- 07 Apr 2013 - 
TL;DR: As editors and readers, the authors should be aware of fraudulent science based on its typical pattern, but they must avoid an atmosphere of distrust, as trust is the essence of scientific exchange and progress.
Journal ArticleDOI

Cell-based cardiovascular repair and regeneration in acute myocardial infarction and chronic ischemic cardiomyopathy – current status and future developments

Christian Templin, +2 more
- 08 Mar 2011 - 
TL;DR: Current evidence for the role and potential of stem and progenitor cells in the pathophysiology and treatment of ischemic heart disease, including the properties, and repair and regenerative capacities of various stem andprogenitor cell populations is provided.
Journal ArticleDOI

Assessment and pathophysiology of microvascular disease: recent progress and clinical implications.

Stefano Masi, +13 more
- 08 Jul 2021 - 
TL;DR: The pathophysiology of microvascular dysfunction emphasizing the role of oxidative stress and its regulation by epigenetic mechanisms, which might represent potential targets for novel interventions beyond conventional approaches, representing a new frontier in CV disease reduction.